International Journal of Cancer Management

Published by: Kowsar

Clinical Outcome and Prognostic Factors in Iranian Breast Cancer Patients After Neoadjuvant Chemotherapy: A Comparative Matched Study

Amir Shahram Yousefi Kashi 1 , Rezvan Montazeri 2 and Afshin Rakhsha 1 , *
Authors Information
1 Cancer Research Center, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Radiation Oncology, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: May 2018, 11 (5); e67739
  • Published Online: May 12, 2018
  • Article Type: Research Article
  • Received: February 23, 2018
  • Accepted: February 28, 2018
  • DOI: 10.5812/ijcm.67739

To Cite: Yousefi Kashi A S, Montazeri R, Rakhsha A. Clinical Outcome and Prognostic Factors in Iranian Breast Cancer Patients After Neoadjuvant Chemotherapy: A Comparative Matched Study, Int J Cancer Manag. 2018 ; 11(5):e67739. doi: 10.5812/ijcm.67739.

Abstract
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization . The Top 10 Causes of Death in 2014, Fact Sheet of WHO Report. 2008.
  • 2. Goya M. Iranian Annual Cancer Registration Report 2015/2016. Tehran, Iran: Ministry of Health and Medical Education, Health Deputy, Center for Disease Control and Prevention; 2007. Persian.
  • 3. Garg PK, Prakash G. Current definition of locally advanced breast cancer. Curr Oncol. 2015;22(5):e409-10. doi: 10.3747/co.22.2697. [PubMed: 26628888]. [PubMed Central: PMC4608421].
  • 4. Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F. Management of locally advanced breast cancer-perspectives and future directions. Nat Rev Clin Oncol. 2015;12(3):147-62. doi: 10.1038/nrclinonc.2015.13. [PubMed: 25668732].
  • 5. Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V, Buchholz TA, et al. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg. 2001;182(6):601-8. [PubMed: 11839324].
  • 6. Berry DA. Adaptive clinical trials in oncology. Nat Rev Clin Oncol. 2011;9(4):199-207. doi: 10.1038/nrclinonc.2011.165. [PubMed: 22064459].
  • 7. Cortazar P, Zhang L, Untch M, Mehta K, Costantino J, Wolmark N, et al. Abstract S1-11: Meta-analysis results from the collaborative trials in neoadjuvant breast cancer (CTNeoBC). Cancer Res. 2014;72(24 Supplement):11. doi: 10.1158/0008-5472.sabcs12-s1-11.
  • 8. Miglietta L, Vanella P, Canobbio L, Parodi MA, Guglielmini P, Boccardo F. Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index. Anticancer Res. 2009;29(5):1621-5. [PubMed: 19443376].
  • 9. Rakhsha A, Anvari A, Razzaghdoust A, Yousefi Kashi AS. Clinical outcome and prognostic factors for very young patients with breast cancer: A comparative matched single institution study in Iran. Int J Cancer Manag. 2017;10(9). doi: 10.5812/ijcm.11772.
  • 10. Colleoni M, Viale G, Goldhirsch A. Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting. Breast. 2009;18 Suppl 3:S137-40. doi: 10.1016/S0960-9776(09)70289-9. [PubMed: 19914533].
  • 11. von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. [PubMed: 22508812].
  • 12. Yoo C, Ahn JH, Jung KH, Kim SB, Kim HH, Shin HJ, et al. Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in patients with breast cancer following neoadjuvant chemotherapy. J Breast Cancer. 2012;15(2):203-10. doi: 10.4048/jbc.2012.15.2.203. [PubMed: 22807938]. [PubMed Central: PMC3395744].
  • 13. Yousefi Kashi AS, Yazdanfar S, Akbari ME, Rakhsha A. Triple negative breast cancer in iranian women: Clinical profile and survival study. Int J Cancer Manag. 2017;10(8). doi: 10.5812/ijcm.10471.
  • 14. Yuan Z, Qu X, Zhang ZT, Wang Y. Neoadjuvant chemotherapy in patients with stages II and III breast cancer. Chin Med J (Engl). 2009;122(24):2993-7. [PubMed: 20137489].
  • 15. Yousefi Ka AS, Mofid B, Mirzaei HR, Azadeh P. Overall survival and related prognostic factors in metastatic brain tumors treated with whole brain radiation therapy. Res J Med Sci. 2010;4(3):213-6. doi: 10.3923/rjmsci.2010.213.216.
  • 16. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-32. doi: 10.1056/NEJMoa020989. [PubMed: 12393819].
  • 17. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001;(30):96-102. [PubMed: 11773300].
  • 18. Yousefi Kashi AS, Khaledi S, Houshyari M. CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients. Iran J Cancer Prev. 2016;9(3). e6233. doi: 10.17795/ijcp-6233. [PubMed: 27703649]. [PubMed Central: PMC5038838].
  • 19. Deo SV, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol. 2003;84(4):192-7. doi: 10.1002/jso.10323. [PubMed: 14756429].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments